Rein Therapeutics, Inc. Common Stock RNTX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $3.22M-75.0% | $12.87M-25.8% | $17.34M+234% | $5.19M+44.3% | ||
| $4.33M-68.3% | $13.66M-25.2% | $18.27M-16.5% | $21.87M-54.6% | ||
| $0-100% | $1K-94.7% | $19K-72.9% | $70K-45.3% | ||
| $6.33M0.0% | $6.33M0.0% | $6.33M— | —— | ||
| $13.5M-68.0% | $42.2M-46.7% | $79.2M— | —— | ||
| $24.16M-61.2% | $62.19M-41.3% | $106.01M+382% | $22.01M-54.6% | ||
| $3.98M+336% | $911K-23.4% | $1.19M-30.8% | $1.72M+42.1% | ||
| $6.18M+7.5% | $5.75M+31.1% | $4.39M+29.6% | $3.38M-24.9% | ||
| $7.24M-7.2% | $7.8M+1.1% | $7.71M+128% | $3.38M-26.1% | ||
| $113K+4.6% | $108K+18.7% | $91K0.0% | $91K0.0% | ||
| -$401.27M-14.2% | -$351.4M-21.8% | -$288.52M-5.8% | -$272.79M-11.1% | ||
| $24.16M-61.2% | $62.19M-41.3% | $106.01M+382% | $22.01M-54.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Rein Therapeutics, Inc. Common Stock's total assets?
- Rein Therapeutics, Inc. Common Stock (RNTX) holds $26.3M in total assets, down 54.4% year over year.
- How much cash does Rein Therapeutics, Inc. Common Stock have?
- Rein Therapeutics, Inc. Common Stock holds $4.4M in cash and equivalents.
- Can Rein Therapeutics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 0.40 — current liabilities exceed current assets.
- Where does Rein Therapeutics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Rein Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.